Ophthalmology Times Staff Reports

1245 S UTICA AVE

Articles

FDA approves OVD for use in ophthalmic surgery

Bausch + Lomb’s ClearVisc dispersive ophthalmic viscosurgical device has received FDA approval for use in ophthalmic surgery.

FDA approves topical corticosteroid for treatment of dry eye disease

The FDA has approved loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of the signs and symptoms of dry eye disease.

Bausch Health: Spin-off of eye health business

This action will result in 2 separate companies,